Should you buy, sell or hold SBI, ITC, IndiGo, Concor, Zydus Lifescience and other shares?
Which stocks to buy, hold or sell today? As Dalal Street enters the May 19 session, here's a look at what brokerages make of some of the key stocks in focus. State Bank of India (SBI), ITC, Granules, InterGlobe Aviation (IndiGo), ConCor, Zydus Lifescience, and other stocks are on their radar today.
Which stocks to buy, hold or sell today? As Dalal Street enters the May 19 session, here's a look at what brokerages make of some of the key stocks in focus.
State Bank of India (SBI), ITC, Granules, InterGlobe Aviation (IndiGo), ConCor, Zydus Lifescience, Gland Pharma, Tata Elxsi, and other stocks are on their radar today.
Do you have any of these stocks in your portfolio?
TRENDING NOW
State Bank of India (SBI)
Most brokerages are bullish on State Bank of India shares after India’s largest lender announced higher-than-estimated earnings for the March quarter of FY23 on Thursday.
CLSA, Jefferies, Goldman Sachs, and Citi each have a ‘buy’ rating, while Morgan Stanley and JP Morgan each maintained an ‘overweight’ stance on the stock.
Brokerage | Rating | Price Target |
CLSA | Buy | Rs 725 |
Morgan Stanley | Overweight | Rs 715 |
JP Morgan | Overweight | Rs 720 |
Jefferies | Buy | Rs 760 |
Goldman Sachs | Buy | Rs 746 |
Citi | Buy | Rs 710 |
Macquarie | Outperform | Rs 695 |
ITC Limited
Amid registering strong Q4 earnings, most brokerages such as Citi, Jefferies, Nomura, and Goldman Sachs have a ‘buy’ rating on the ITC shares. The cigarette-to-hotels conglomerate on Thursday announced higher-than-expectations numbers in the March quarter of FY23.
Brokerage | Rating | Price Target |
Morgan Stanley | Overweight | Rs 474 |
JP Morgan | Overweight | Rs 425 |
Citi | Buy | Rs 480 |
Jefferies | buy | Rs 520 |
Nomura | Buy | Rs 485 |
Goldman Sachs | Buy | Rs 470 |
InterGlobe Aviation (IndiGo)
On the back of better performance in Q4 earnings, the majority of the global brokerages are upbeat on IndiGo shares as JP Morgan and Morgan Stanley each retained an ‘overweight’ rating. At the same time, Citi and Goldman Sachs have a ‘buy’ call on the aviation stock.
Brokerage | Rating | Price Target |
JP Morgan | Overweight | Rs 2,700 |
Morgan Stanley | Overweight | Rs 3,126 |
Citi | Buy | Rs 2,400 |
Jefferies | Underperform | Rs 1,950 |
Credit Suisse | Outperform | Rs 2,450 |
Goldman Sachs | Buy | Rs 2,600 |
ConCor
Brokerages are divided on Container Corporation – a state-run company – after the government-owned firm’s margins for the quarter came below estimate. Morgan Stanley has an ‘equal weight’, Macquarie ‘underperform’ and Nomura ‘neutral’ rating on the stock.
Brokerage | Rating | Price Target |
Morgan Stanley | Equal weight | Rs 660 |
Macquarie | Underperform | Rs 620 |
Nomura | Neutral | Rs 635 |
Zydus Lifescience
Brokerage | Rating | Price Target |
Morgan Stanley | Overweight | Rs 646 |
Jefferies | Buy | Rs 585 |
Nomura | Buy | Rs 540 |
Macquarie | Underperform | Rs 400 |
GAIL India
Brokerage | Rating | Price Target |
Morgan Stanley | Overweight | Rs 135 |
Citi | Buy | Rs 125 |
Jefferies | Hold | Rs 110 |
Macquarie | Outperform | Rs 140 |
Gland Pharma
Brokerage | Rating | Price Target |
Goldman Sachs | Buy | Rs 1,475 |
Citi | Sell | Rs 925 |
Jefferies | Underperform | Rs 1,065 |
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
10:21 am